TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Entero Healthcare Solu L
ENTERO

Entero Healthcare Solu L Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 62/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹1,821.8

Change

-30.4 (-1.64%)

Open

₹1,854.0

Prev. Close

₹1,852.2

Day High

₹1,855.2

Day Low

₹1,809.0

Volume Analysis

Traded

110,434

Delivered

65,927

Delivery %

59.7%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Low return on equity (6.94%)
  • •Low operating margin (4.4%)

Opportunities (1)

  • •Strong 3-year revenue growth (25.9%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,894.54 ₹1,874.87 ₹1,848.34 ₹1,828.67 ₹1,802.14 ₹1,782.47 ₹1,755.94
Fibonacci ₹1,874.87 ₹1,857.22 ₹1,846.32 ₹1,828.67 ₹1,811.02 ₹1,800.12 ₹1,782.47
Camarilla ₹1,834.51 ₹1,830.27 ₹1,826.04 ₹1,828.67 ₹1,817.57 ₹1,813.33 ₹1,809.1

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+61.28%

1 Week

+1.46%

1 Month

+0.73%

3 Months

+53.09%

6 Months

+46.14%

1 Year

+68.19%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹480.44

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

9.2%

Net margin 2.36% × asset turnover 1.83x × equity multiplier 2.13x

Company Overview

Sector

Consumer Services

Market Cap

₹8,019 Cr

P/E (TTM)

62.1

ROE

6.94%

Book Value

₹388.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.

TopFund Analysis

Entero Healthcare Solu L lands in the middle of the pack on TopFund's composite fundamentals check within the Consumer Services sector, at 62/100. The strongest factor is Growth (100/100), while Valuation (20/100) is the weakest area to weigh before deciding. Notably: Low return on equity (6.94%); low operating margin (4.4%). FII holding has been falling.

TopFund Score — Fundamentals Quality

62/100 — Average

Data confidence: 77/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

94

Growth

100

Valuation

20

Cash Flow

24

Corporate Governance

56

Momentum

92

Institutional Ownership

44

Business Quality

39

Risk & Volatility

77

Liquidity

89

From Screener.in

  • +Company is expected to give good quarter
  • +Company has delivered good profit growth of 57.3% CAGR over last 5 years
  • +Company's working capital requirements have reduced from 49.4 days to 34.8 days
  • −Stock is trading at 4.75 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of 6.04% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Closure of Trading Window 23 Sep

Trading window closed from October 1, 2026 until 48 hours after Q2 FY2026-27 results.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 22 Sep

Entero Healthcare to attend Arihant Capital virtual group meeting on September 29, 2026.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 22 Sep 22 Sep
Entero Healthcare Solutions Limited Has informed About General Updates 12 Sep

GST Authority levied Rs. 12.92 lakh penalty on ACE Cardiopathy for non-generation of e-invoice, paid under protest.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 26 Aug 26 Aug

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 899 996 993 1,034 1,097 1,301 1,359 1,339 1,404 1,571 1,707 1,910 1,940
Expenses + 873 968 964 1,005 1,067 1,258 1,309 1,290 1,354 1,509 1,639 1,824 1,844
Operating Profit 26 29 29 29 30 42 50 49 50 62 68 86 97
OPM % 2.9% 2.9% 2.9% 2.8% 2.8% 3.3% 3.7% 3.6% 3.6% 4.0% 4.0% 4.5% 5.0%
Other Income + 1 2 2 9 13 11 8 7 6 5 -4 4 3
Interest 14 18 16 17 10 11 10 10 11 12 14 17 21
Depreciation 6 6 6 7 7 7 8 8 9 10 10 15 12
Profit before tax 7 7 8 14 27 35 39 37 36 45 40 58 67
Tax % 6.0% 23.0% 16.0% -56.0% 25.0% 25.0% 25.0% 16.0% 17.0% 18.0% 16.0% 22.0% 22.0%
Net Profit + 6 5 7 21 21 26 29 31 30 37 34 45 52
EPS in Rs 15 3 4 5 5 5 6 6 6 7 6 6 9
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 1,350 1,773 2,522 3,300 3,922 5,096 6,591 7,128
Expenses + 1,326 1,758 2,498 3,236 3,810 4,924 6,325 6,815
Operating Profit 23 15 24 64 112 172 266 313
OPM % 1.7% 0.8% 1.0% 1.9% 2.9% 3.4% 4.0% 4.4%
Other Income + 5 11 4 6 14 39 11 8
Interest 13 20 29 49 66 42 54 64
Depreciation 12 16 20 24 25 31 43 47
Profit before tax 4 -11 -20 -4 36 139 179 210
Tax % 67.0% 42.0% 49.0% 201.0% -12.0% 23.0% 19.0% —
Net Profit + 1 -15 -29 -11 40 107 146 168
EPS in Rs 94 -1,551 -78 -28 9 22 26 29
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves -16 -32 -62 -73 1,595 1,681 1,645
Borrowings + 603 720 974 1,101 338 385 677
Other Liabilities + 162 147 210 275 369 593 1,234
Total Liabilities 749 836 1,125 1,308 2,345 2,703 3,600
Fixed Assets + 186 189 262 268 289 559 958
CWIP 2 2 1 0 0 0 2
Investments 0 0 0 0 0 58 130
Other Assets + 560 645 863 1,040 2,056 2,085 2,510
Total Assets 749 836 1,125 1,308 2,345 2,703 3,600
Equity Capital 0 0 4 4 43 44 44

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + -37 -69 -35 -45 -37 -77 96
Cash from Investing Activity + -203 -31 -162 -49 -704 232 -302
Cash from Financing Activity + 217 89 211 73 863 -74 124
Net Cash Flow -23 -11 14 -21 122 82 -82
CFO/OP -134 -430 -100 -51 -21 -23 56
Free Cash Flow -81 -78 -45 -51 -41 -87 29

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 52.44% → 52.4%
  Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 21.99% 22.18% 16.02% 16.59% 18.03% 20.19% 23.26% 26.03% 26.94% 27.77%
Promoters 52.44% 52.44% 52.44% 52.44% 52.42% 52.42% 52.42% 52.42% 52.42% 52.4%
FII 23.3% 23.32% 23.82% 22.2% 19.92% 17.21% 14.68% 5.14% 4.03% 4.36%
DII 2.28% 2.06% 7.73% 8.78% 9.63% 10.19% 9.64% 16.42% 16.62% 15.48%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Consumer Services — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Entero Healthcare Solu L (this stock) 8,019 62.1 4.75 6.94%
Medplus Health Serv Ltd 7,868 37.4 3.97 11.6%
V2 Retail Limited 7,830 49.4 8.67 22.9%
Lemon Tree Hotels Ltd 8,403 32.8 6.02 19.2%
Waterways Leisure Tour L 7,617 190.0 — 92.3%
Electronics Mart Ind Ltd 7,361 37.5 4.52 6.24%
Shiprocket Limited 8,749 — — -5.14%

Which Mutual Funds Hold Entero Healthcare Solu L?

Frequently Asked Questions about Entero Healthcare Solu L

Community Sentiment

What are other investors saying about Entero Healthcare Solu L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.